HI
Hawaii Senate Bill SCR133

Hawaii 2023 Regular Session

Hawaii Senate Bill SCR133

Introduced
3/10/23  

Caption

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

Impact

If enacted, SCR133 would lead to the formation of a working group tasked with evaluating federal, state, and local laws concerning psilocybin. It aims to assess existing medical and scientific research about psilocybin's safety and efficacy in treating significant mental health disorders. The working group would also investigate jurisdictions where psilocybin is legally used and develop a strategic plan for its therapeutic availability to adults aged twenty-one and over. The group is expected to report its findings and propose legislation to the legislature prior to the 2024 session, contributing to informed discussions around mental health care reforms in the state.

Summary

SCR133, introduced in the State of Hawaii's Thirty-Second Legislature in 2023, seeks to address the growing mental health crisis by requesting the Department of Health to establish a Therapeutic Psilocybin Working Group. The resolution highlights the urgency of mental health issues exacerbated by a shortage of professionals and suggests that psilocybin, which has shown effectiveness in treating various conditions such as PTSD, depression, and anxiety, could be a potential solution. This initiative aligns with the recent recognition by the FDA of psilocybin as a 'breakthrough therapy' for treatment-resistant depression.

Contention

Notable points of contention may arise concerning the regulation and accessibility of psilocybin, especially considering its current legal status and societal perceptions. Supporters advocate for its potential to provide innovative treatment options amid prevailing mental health challenges, while opponents may express concerns about the implications of normalizing a psychedelic substance within therapeutic environments. The establishment of such a working group may lead to debates regarding regulation, safety protocols, and ethical considerations for psilocybin's medicinal use.

Latest SCR133 Activity

Companion Bills

HI SR153

Same As Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

HI HCR202

Same As Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

Previously Filed As

HI SCR205

Requesting The Department Of Health To Convene A Community Noise Working Group To Discuss Policies And Legislation With Respect To Noise Sources Affecting The Community.

HI SCR16

Requesting The Department Of Health To Convene A Task Force To Identify And Develop Minimum Professional Standards For Community Health Worker Training Programs.

HI SCR180

Requesting The Department Of Health To Convene A Working Group To Prepare And Develop Solutions And Make Recommendations For The Recruitment And Retention Of Nurses To Address The Shortage Of The Nursing And Health Care Workforce In The State.

HI SCR174

Requesting The Department Of Health To Convene A Twenty-first Century Data Governance Task Force To Assess Current Demographic Data Collection, Processing, Retention, And Sharing Procedures Utilized By All State Agencies.

HI SCR100

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.

HI SCR172

Requesting The Department Of Health To Convene A Demolition Waste Reduction Working Group.

HI SCR118

Requesting The Department Of Health To Convene A Health Care Facilities Labor Standards Working Group To Research, Assess, And Make Recommendations On The Best Practices In Labor Standards That Can Be Implemented At Hospitals, Care Homes, And Dialysis Facilities In The State.

HI SCR227

Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients.

Similar Bills

HI SR88

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Longterm Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.

HI SR153

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

HI HR206

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

HI HCR202

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

HI SB3160

Relating To Psilocybin.

HI HB2400

Relating To Psilocybin.

HI SCR100

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.

HI SB1454

Relating To Psilocybin.